ELEMENTS (5246) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Quarterly revenue rose 715 million yen, up 65.5–66% year-over-year, driven by LIQUID eKYC and AI cloud-based authentication solutions.
EBITDA reached 91 million yen, up 237% year-over-year; operating loss narrowed to -13 to -13.9 million yen.
Net loss attributable to shareholders widened to 51–51.8 million yen year-over-year.
Acquisition of Polarify (PolariPhi) completed, with 95.01% of shares acquired for 1,539 million yen, making it a consolidated subsidiary.
Focus remains on domestic market expansion, especially in digital transformation (DX) and eKYC services.
Financial highlights
Revenue: 715 million yen (+65.5–66% YoY); personal authentication solutions contributed 707 million yen (+67% YoY).
Gross profit: 331.8–634 million yen (+66% YoY); gross margin maintained at 88.7%.
EBITDA: 91 million yen (+64 million yen YoY); operating loss: -13 to -13.9 million yen (improved YoY).
Net loss attributable to parent: -51 to -51.8 million yen (down YoY).
Total assets rose to 5,354 million yen, mainly due to higher cash, work-in-progress, and tangible fixed assets.
Outlook and guidance
FY2025 revenue forecast: 3,730–3,900 million yen (+46.5–53.2% YoY); personal authentication revenue: 3,681–3,851 million yen.
EBITDA expected to remain positive; operating and net income to remain negative.
Guidance excludes impact of newly consolidated PolariPhi; updates to be disclosed when available.
Mid-term targets for FY2027: revenue 6–6.5 billion yen, operating margin 15%, EBITDA margin 25%, with 30%+ CAGR.
Latest events from ELEMENTS
- Revenue up 53%, net loss widened; FY26 targets profitability and strong authentication growth.5246
Q4 202513 Jan 2026 - Record revenue growth offset by higher costs and net loss; outlook remains unchanged.5246
Q3 202514 Oct 2025 - Record revenue growth offset by a large impairment-driven net loss and revised outlook.5246
Q2 202514 Jul 2025 - Revenue up 41%, EBITDA positive, and capital strengthened after Admedica acquisition.5246
Q3 202413 Jun 2025 - Revenue and EBITDA rose sharply, guidance raised, and capital structure strengthened.5246
Q2 202413 Jun 2025 - Record revenue, first full-year profit, and Polarify deal set stage for future growth.5246
Q4 20246 Jun 2025